Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 361

1.

Estimation of global insulin use for type 2 diabetes, 2018-30: a microsimulation analysis.

Basu S, Yudkin JS, Kehlenbrink S, Davies JI, Wild SH, Lipska KJ, Sussman JB, Beran D.

Lancet Diabetes Endocrinol. 2019 Jan;7(1):25-33. doi: 10.1016/S2213-8587(18)30303-6. Epub 2018 Nov 21. Erratum in: Lancet Diabetes Endocrinol. 2019 Jan;7(1):e1.

PMID:
30470520
2.

Reducing chronic disease through changes in food aid: A microsimulation of nutrition and cardiometabolic disease among Palestinian refugees in the Middle East.

Basu S, Yudkin JS, Berkowitz SA, Jawad M, Millett C.

PLoS Med. 2018 Nov 20;15(11):e1002700. doi: 10.1371/journal.pmed.1002700. eCollection 2018 Nov.

3.

Availability and Affordability of Essential Medicines: Implications for Global Diabetes Treatment.

Beran D, Ewen M, Lipska K, Hirsch IB, Yudkin JS.

Curr Diab Rep. 2018 Jun 16;18(8):48. doi: 10.1007/s11892-018-1019-z. Review.

PMID:
29907884
4.

Erratum. Why Are We Failing to Address the Issue of Access to Insulin? A National and Global Perspective. Diabetes Care 2018;41:1125-1131.

Beran D, Hirsch IB, Yudkin JS.

Diabetes Care. 2018 Sep;41(9):2048. doi: 10.2337/dc18-er09a. Epub 2018 Jun 15. No abstract available.

5.

Why Are We Failing to Address the Issue of Access to Insulin? A National and Global Perspective.

Beran D, Hirsch IB, Yudkin JS.

Diabetes Care. 2018 Jun;41(6):1125-1131. doi: 10.2337/dc17-2123. Erratum in: Diabetes Care. 2018 Jun 15;:.

PMID:
29784696
6.

Associations of stunting in early childhood with cardiometabolic risk factors in adulthood.

De Lucia Rolfe E, de França GVA, Vianna CA, Gigante DP, Miranda JJ, Yudkin JS, Horta BL, Ong KK.

PLoS One. 2018 Apr 11;13(4):e0192196. doi: 10.1371/journal.pone.0192196. eCollection 2018.

7.

Inequalities in non-communicable diseases in Israel.

Yudkin JS.

Lancet. 2018 Feb 10;391(10120):536-537. doi: 10.1016/S0140-6736(17)32473-X. No abstract available.

PMID:
29617238
8.

Validation of Risk Equations for Complications of Type 2 Diabetes (RECODe) Using Individual Participant Data From Diverse Longitudinal Cohorts in the U.S.

Basu S, Sussman JB, Berkowitz SA, Hayward RA, Bertoni AG, Correa A, Mwasongwe S, Yudkin JS.

Diabetes Care. 2018 Mar;41(3):586-595. doi: 10.2337/dc17-2002. Epub 2017 Dec 21.

PMID:
29269511
9.

Development and validation of Risk Equations for Complications Of type 2 Diabetes (RECODe) using individual participant data from randomised trials.

Basu S, Sussman JB, Berkowitz SA, Hayward RA, Yudkin JS.

Lancet Diabetes Endocrinol. 2017 Oct;5(10):788-798. doi: 10.1016/S2213-8587(17)30221-8. Epub 2017 Aug 10.

10.

Diabetes in sub-Saharan Africa: from clinical care to health policy.

Atun R, Davies JI, Gale EAM, Bärnighausen T, Beran D, Kengne AP, Levitt NS, Mangugu FW, Nyirenda MJ, Ogle GD, Ramaiya K, Sewankambo NK, Sobngwi E, Tesfaye S, Yudkin JS, Basu S, Bommer C, Heesemann E, Manne-Goehler J, Postolovska I, Sagalova V, Vollmer S, Abbas ZG, Ammon B, Angamo MT, Annamreddi A, Awasthi A, Besançon S, Bhadriraju S, Binagwaho A, Burgess PI, Burton MJ, Chai J, Chilunga FP, Chipendo P, Conn A, Joel DR, Eagan AW, Gishoma C, Ho J, Jong S, Kakarmath SS, Khan Y, Kharel R, Kyle MA, Lee SC, Lichtman A, Malm CP, Mbaye MN, Muhimpundu MA, Mwagomba BM, Mwangi KJ, Nair M, Niyonsenga SP, Njuguna B, Okafor OLO, Okunade O, Park PH, Pastakia SD, Pekny C, Reja A, Rotimi CN, Rwunganira S, Sando D, Sarriera G, Sharma A, Sidibe A, Siraj ES, Syed AS, Van Acker K, Werfalli M.

Lancet Diabetes Endocrinol. 2017 Aug;5(8):622-667. doi: 10.1016/S2213-8587(17)30181-X. Epub 2017 Jul 5. Review. No abstract available.

PMID:
28688818
11.

Genomic ancestry and education level independently influence abdominal fat distributions in a Brazilian admixed population.

França GVA, De Lucia Rolfe E, Horta BL, Gigante DP, Yudkin JS, Ong KK, Victora CG.

PLoS One. 2017 Jun 5;12(6):e0179085. doi: 10.1371/journal.pone.0179085. eCollection 2017. Erratum in: PLoS One. 2018 Apr 17;13(4):e0196265.

12.

Essential medicines and access to insulin.

Gill G, Yudkin JS, Tesfaye S, de Courten M, Gale E, Motala A, Ramaiya K, Unwin N, Wild S.

Lancet Diabetes Endocrinol. 2017 May;5(5):324-325. doi: 10.1016/S2213-8587(17)30090-6. Epub 2017 Mar 18. No abstract available.

PMID:
28330591
13.

Exercise effects on perivascular adipose tissue: endocrine and paracrine determinants of vascular function.

Boa BCS, Yudkin JS, van Hinsbergh VWM, Bouskela E, Eringa EC.

Br J Pharmacol. 2017 Oct;174(20):3466-3481. doi: 10.1111/bph.13732. Epub 2017 Mar 16. Review.

14.

The association of hyperglycaemia with prevalent tuberculosis: a population-based cross-sectional study.

Bailey SL, Ayles H, Beyers N, Godfrey-Faussett P, Muyoyeta M, du Toit E, Yudkin JS, Floyd S.

BMC Infect Dis. 2016 Dec 5;16(1):733.

15.

Diabetes diagnosis and care in sub-Saharan Africa: pooled analysis of individual data from 12 countries.

Manne-Goehler J, Atun R, Stokes A, Goehler A, Houinato D, Houehanou C, Hambou MM, Mbenza BL, Sobngwi E, Balde N, Mwangi JK, Gathecha G, Ngugi PW, Wesseh CS, Damasceno A, Lunet N, Bovet P, Labadarios D, Zuma K, Mayige M, Kagaruki G, Ramaiya K, Agoudavi K, Guwatudde D, Bahendeka SK, Mutungi G, Geldsetzer P, Levitt NS, Salomon JA, Yudkin JS, Vollmer S, Bärnighausen T.

Lancet Diabetes Endocrinol. 2016 Nov;4(11):903-912. doi: 10.1016/S2213-8587(16)30181-4. Epub 2016 Oct 7.

PMID:
27727123
16.

Comparative effectiveness and cost-effectiveness of treat-to-target versus benefit-based tailored treatment of type 2 diabetes in low-income and middle-income countries: a modelling analysis.

Basu S, Shankar V, Yudkin JS.

Lancet Diabetes Endocrinol. 2016 Nov;4(11):922-932. doi: 10.1016/S2213-8587(16)30270-4. Epub 2016 Oct 4.

17.

Perivascular fat in human muscle.

Meijer RI, Serne EH, Yudkin JS, van Hinsbergh VW, Smulders YM, Eringa EC.

Lancet Diabetes Endocrinol. 2016 Nov;4(11):958. doi: 10.1016/S2213-8587(15)00520-3. Epub 2016 Feb 24. No abstract available.

PMID:
26928650
18.

Diabetes mellitus in Zambia and the Western Cape province of South Africa: Prevalence, risk factors, diagnosis and management.

Bailey SL, Ayles H, Beyers N, Godfrey-Faussett P, Muyoyeta M, du Toit E, Yudkin JS, Floyd S.

Diabetes Res Clin Pract. 2016 Aug;118:1-11. doi: 10.1016/j.diabres.2016.05.001. Epub 2016 May 7.

19.

"Prediabetes": Are There Problems With This Label? Yes, the Label Creates Further Problems!

Yudkin JS.

Diabetes Care. 2016 Aug;39(8):1468-71. doi: 10.2337/dc15-2113.

PMID:
27457638
20.

Liberating data: the WHO response - Authors' reply.

Davies J, Yudkin JS, Atun R.

Lancet Diabetes Endocrinol. 2016 Aug;4(8):648-9. doi: 10.1016/S2213-8587(16)30114-0. Epub 2016 Jun 16. No abstract available.

PMID:
27318674
21.

Guidelines for treating risk factors should include tools for shared decision making.

Yudkin JS, Kavanagh J, McCormack JP.

BMJ. 2016 Jun 14;353:i3147. doi: 10.1136/bmj.i3147. No abstract available.

PMID:
27302041
22.

Liberating data: the crucial weapon in the fight against NCDs.

Davies J, Yudkin JS, Atun R.

Lancet Diabetes Endocrinol. 2016 Mar;4(3):197-198. doi: 10.1016/S2213-8587(16)00037-1. Epub 2016 Jan 28. No abstract available.

PMID:
26827114
23.

Alternative Strategies to Achieve Cardiovascular Mortality Goals in China and India: A Microsimulation of Target- Versus Risk-Based Blood Pressure Treatment.

Basu S, Yudkin JS, Sussman JB, Millett C, Hayward RA.

Circulation. 2016 Mar 1;133(9):840-8. doi: 10.1161/CIRCULATIONAHA.115.019985. Epub 2016 Jan 13.

24.

Preventing cardiovascular events with empagliflozin: at what cost?

Naci H, Basu S, Yudkin JS.

Lancet Diabetes Endocrinol. 2015 Dec;3(12):931. doi: 10.1016/S2213-8587(15)00439-8. No abstract available.

PMID:
26590682
25.

Rethinking the appraisal and approval of drugs for type 2 diabetes.

Naci H, Lehman R, Wouters OJ, Goldacre B, Yudkin JS.

BMJ. 2015 Oct 9;351:h5260. doi: 10.1136/bmj.h5260. Review. No abstract available.

PMID:
26452524
26.

Ten Commandments for patient-centred treatment.

Lehman R, Tejani AM, McCormack J, Perry T, Yudkin JS.

Br J Gen Pract. 2015 Oct;65(639):532-3. doi: 10.3399/bjgp15X687001. No abstract available.

27.

Associations of birth weight, linear growth and relative weight gain throughout life with abdominal fat depots in adulthood: the 1982 Pelotas (Brazil) birth cohort study.

Araújo de França GV, De Lucia Rolfe E, Horta BL, Gigante DP, Yudkin JS, Ong KK, Victora CG.

Int J Obes (Lond). 2016 Jan;40(1):14-21. doi: 10.1038/ijo.2015.192. Epub 2015 Sep 23.

28.
29.

Diabetes prevention in England.

Yudkin JS, Millett C.

Lancet Diabetes Endocrinol. 2015 Jul;3(7):502. doi: 10.1016/S2213-8587(15)00211-9. No abstract available.

PMID:
26138168
30.

In defence of NICE draft type 2 diabetes guidelines.

Beran D, Yudkin JS.

Lancet Diabetes Endocrinol. 2015 Jun;3(6):406. doi: 10.1016/S2213-8587(15)00131-X. No abstract available.

PMID:
26003753
31.

Insulin-induced changes in skeletal muscle microvascular perfusion are dependent upon perivascular adipose tissue in women.

Meijer RI, Serné EH, Korkmaz HI, van der Peet DL, de Boer MP, Niessen HW, van Hinsbergh VW, Yudkin JS, Smulders YM, Eringa EC.

Diabetologia. 2015 Aug;58(8):1907-15. doi: 10.1007/s00125-015-3606-8. Epub 2015 May 24.

32.

The health system and population health implications of large-scale diabetes screening in India: a microsimulation model of alternative approaches.

Basu S, Millett C, Vijan S, Hayward RA, Kinra S, Ahuja R, Yudkin JS.

PLoS Med. 2015 May 19;12(5):e1001827; discussion e1001827. doi: 10.1371/journal.pmed.1001827. eCollection 2015 May.

33.

Politics, medical journals, the medical profession and the Israel lobby.

Yudkin JS, Leaning J.

BMJ. 2015 May 12;350:h2377. doi: 10.1136/bmj.h2377. No abstract available.

PMID:
25985332
34.

Comment on Cefalu et Al. The alarming and rising costs of diabetes and prediabetes: a call for action! Diabetes care 2014;37:3137-3138.

Yudkin JS, Montori VM.

Diabetes Care. 2015 May;38(5):e81. doi: 10.2337/dc14-2910. No abstract available.

PMID:
25908164
35.

The Lancet Diabetes & Endocrinology needs a more rigorous conflict of interest policy.

Schmidt TA, Yudkin JS.

Lancet Diabetes Endocrinol. 2015 Mar;3(3):168. doi: 10.1016/S2213-8587(15)00006-6. No abstract available.

PMID:
25702245
36.

Cardiovascular and all-cause mortality in relation to various anthropometric measures of obesity in Europeans.

Song X, Jousilahti P, Stehouwer CD, Söderberg S, Onat A, Laatikainen T, Yudkin JS, Dankner R, Morris R, Tuomilehto J, Qiao Q; DECODE Study Group.

Nutr Metab Cardiovasc Dis. 2015 Mar;25(3):295-304. doi: 10.1016/j.numecd.2014.09.004. Epub 2014 Sep 20.

PMID:
25315666
37.

Improving global access to medicines for non-communicable diseases.

Beran D, Perrin C, Billo N, Yudkin JS.

Lancet Glob Health. 2014 Oct;2(10):e561-2. doi: 10.1016/S2214-109X(14)70189-5. No abstract available.

38.

Cardiovascular outcome trials of glucose-lowering strategies in type 2 diabetes.

Yudkin JS, Vijan S, Sussman JB, Lehman R, Goldacre BM.

Lancet. 2014 Sep 20;384(9948):1095. doi: 10.1016/S0140-6736(14)61671-8. No abstract available.

PMID:
25241716
39.

Lack of impact of angiotensin-converting enzyme gene polymorphism and salt intake on insulin resistance and limb blood flow.

Foo M, Coppack SW, Denver AE, Bulmer K, Yudkin JS.

Clin Endocrinol (Oxf). 2015 Jan;82(1):76-83. doi: 10.1111/cen.12595. Epub 2014 Nov 3.

PMID:
25154650
40.

The epidemic of pre-diabetes: the medicine and the politics.

Yudkin JS, Montori VM.

BMJ. 2014 Jul 15;349:g4485. doi: 10.1136/bmj.g4485. No abstract available. Erratum in: BMJ. 2014;349:g4683.

41.

Rigorous science is needed to justify the centralisation of services.

Yudkin JS.

BMJ. 2014 Jul 1;349:g4324. doi: 10.1136/bmj.g4324. No abstract available.

PMID:
24986867
42.

Effect of patients' risks and preferences on health gains with plasma glucose level lowering in type 2 diabetes mellitus.

Vijan S, Sussman JB, Yudkin JS, Hayward RA.

JAMA Intern Med. 2014 Aug;174(8):1227-34. doi: 10.1001/jamainternmed.2014.2894.

43.

Use and out-of-pocket costs of insulin for type 2 diabetes mellitus from 2000 through 2010.

Lipska KJ, Ross JS, Van Houten HK, Beran D, Yudkin JS, Shah ND.

JAMA. 2014 Jun 11;311(22):2331-3. doi: 10.1001/jama.2014.6316. No abstract available.

44.

Obesity attenuates gender differences in cardiovascular mortality.

Song X, Tabák AG, Zethelius B, Yudkin JS, Söderberg S, Laatikainen T, Stehouwer CD, Dankner R, Jousilahti P, Onat A, Nilsson PM, Satman I, Vaccaro O, Tuomilehto J, Qiao Q; DECODE Study Group.

Cardiovasc Diabetol. 2014 Oct 19;13:144. doi: 10.1186/s12933-014-0144-5.

45.

Effects of fish oil on lipid profile and other metabolic outcomes in HIV-infected patients on antiretroviral therapy: a randomized placebo-controlled trial.

Oliveira JM, Rondó PH, Yudkin JS, Souza JM, Pereira TN, Catalani AW, Picone CM, Segurado AA.

Int J STD AIDS. 2014 Feb;25(2):96-104. doi: 10.1177/0956462413513748. Epub 2013 Nov 27.

PMID:
24285599
46.

Comparison of various surrogate obesity indicators as predictors of cardiovascular mortality in four European populations.

Song X, Jousilahti P, Stehouwer CD, Söderberg S, Onat A, Laatikainen T, Yudkin JS, Dankner R, Morris R, Tuomilehto J, Qiao Q.

Eur J Clin Nutr. 2013 Dec;67(12):1298-302. doi: 10.1038/ejcn.2013.203. Epub 2013 Oct 23.

PMID:
24149442
47.

The double scandal of insulin.

Beran D, Yudkin JS.

J R Coll Physicians Edinb. 2013;43(3):194-6. doi: 10.4997/JRCPE.2013.301. No abstract available.

PMID:
24087795
48.

Global reality of type 1 diabetes care in 2013.

Beran D, Yudkin JS, Atkinson MA.

Diabetes Care. 2013 Sep;36(9):e144. doi: 10.2337/dc13-0744. No abstract available.

49.

European Medicines Agency must take account of cardiovascular harm associated with degludec insulin.

Schmidt TA, Rosen CJ, Yudkin JS.

BMJ. 2013 Jun 11;346:f3731. doi: 10.1136/bmj.f3731. No abstract available.

PMID:
23757746
50.

Act now against new NHS competition regulations: an open letter to the BMA and the Academy of Medical Royal Colleges calls on them to make a joint public statement of opposition to the amended section 75 regulations.

Davis J, Banks I, Wrigley D, Peedell C, Pollock A, McPherson K, McKee M, Irving WL, Crome P, Greenhalgh T, Holland W, Evans D, Maryon-Davis A, Smyth A, Fleming P, Coleman M, Sharp DJ, Whincup P, Logan S, Cook D, Moore R, Rawaf S, McEewen J, West R, Yudkin JS, Clarke A, Finer N, Domizio P, Bambra C, Jones A, Feder G, Scott-Samuel A, Irvine L, Sharma A, Fitchett M, Boomla K, Folb J, Paul A, McCoy D, Tallis R, Burgess-Allen J, Edwards M, Tomlinson J, Colvin D, Gore J, Brown K, Mitchel S, Lau A, Sayer M, Clark L, Silverman R, Marmot S, Rainbow D, Carter L, Mann N, Fielding R, Logan J, Tebboth L, Arnold N, Stobbart K, Cabot K, Finer S, Edwards M, Davies D, Buttivant H, Kraemer S, Newell J, Griffiths A, Fitzgerald R, Macgibbon R, Lee A, Macklon AF, Hobson E, Jenner D, Jacobson B, Timmis A, Salim A, Evans-Jones J, Caan W, Awsare N, Pride N, Suckling R, Bratty C, Rossiter B, Hawkins D, Currie J, Camilleri-Ferrante C, Fluxman J, Bhatti O, Anson J, Etherington R, Lawrence D, Fell H, Clarke E, Ormerod J, Ormerod O, Ireland M, Duncan JA, Chandy R, Mindell J, Mullen P, Bennett-Richards P, Hirst J, Murphy E, Martin P, Lowes S, Fleming P, Grunewald R, Reeve J, Schweiger M, Coates J, Farrelly G, Chamberlain MA, Lewis G, Young J, Scott B, Gibbs J, Landers A, Deveson P, Ingrams G, Leigh M, Gawler J, Ford A, Nixon J, McCartney M, Bareford D, Singh S, Lockwood K, Cripwell M, Ehrhardt P, Bell D, Wortley P, Tomlinson L, Hotchkiss J, Ford S, Turner G, Reissman G, Lewis D, Johnstone C, Tomson M, Torabi P, Bell D, Tomson D, Tulloch A, Johnston S, Dickinson J, McElderry E, Ross W, Holt K, Logan M, Klonin H, Jenner D, Danby J, Goodger V, Puntis J, Dickson H, Gould DA, Livingstone A, Lefevre D, Kendall B, Singh G, Hall P, Darling J, Hamlyn AN, Patel A, Erskine J, Fisher B, Hughes R, Highton C, Venning H, Singer R, Brearey S, Sikorski J, Paintin D, Feehally J, Savage W, Freud KM, Holt VJ, Gill A, Waterston T, Souza Rd, Hopkinson N, Beadsworth M, Franks A, Daley H, Cullinan P, Basarab A, Folb J, Gurling H, Zinkin P, Kirwin S, Buhrs E, Brown R, West A, Marlowe G, Fellows G, Main J, Applebee J, Koperski M, Jones P, Macfarlane A, Beer N, Mason R, West R, Eisner M, Smailes A, Timms P, Knight D, Jones C, Wesby B, Lyttelton L, Morrison R, Bossano D, Walker J, Davies G, Godfrey P, Wolfe I, Nsutebu E, Stevenson N, Cheeroth S, Miller J, Johnson G, Noor R, Hall A, Bostock D, Michael B, Sharvill J, Macpherson J, Lewis D, Ma R, Middleton J, Jeffreys A, Cole J, Boswell JP, Bury B, Mitchison S, Kinmonth AL, Young G, Maclennan I, Munday P.

BMJ. 2013 Mar 20;346:f1819. doi: 10.1136/bmj.f1819. No abstract available.

Supplemental Content

Loading ...
Support Center